Intuitive Surgical (ISRG) Gets FDA Nod for da Vinci's New Label

Intuitive Surgical (ISRG) recently announced the FDA 510(k) clearance of a labeling revision for its da Vinci X and Xi specific to radical prostatectomy.This clearance was granted based on real-world evidence (RWE) gathered between 2007 and 2014, which shows that the overall five to 10-year survival rate after radical prostatectomy with robotic assistance is similar to that of non-robotic radical prostatectomy.Price PerformanceIn the past six months, ISRG shares have gained 34.7% compared with the industry’ ...